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Abstract
Background: Canada, when compared to other OECD countries, ranks poorly with respect to innovation and
innovation adoption while struggling with increasing health system costs. As a result of its failure to innovate,
the Canadian health system will struggle to meet the needs and demands of both current and future populations.
The purpose of this initiative was to explore if a competition-based reverse innovation challenge could mobilize
and stimulate current and future leaders to identify and lead potential reverse innovation projects that address
health system challenges in Canada.
Methods: An open call for applications took place over a 4-month period. Applicants were enticed to submit
to the competition with a $50,000 prize for the top submission to finance their project. Leaders from a wide
cross-section of sectors collectively developed evaluation criteria and graded the submissions. The criteria evaluated:
proof of concept, potential value, financial impact, feasibility, and scalability as well as the use of prize money and
innovation team.
Results: The competition received 12 submissions from across Canada that identified potential reverse innovations
from 18 unique geographical locations that were considered developing and/or emerging markets. The various
submissions addressed health system challenges relating to education, mobile health, aboriginal health, immigrant
health, seniors health and women’s health and wellness. Of the original 12 submissions, 5 finalists were chosen and
publically profiled, and 1 was chosen to receive the top prize.
Conclusions: The results of this initiative demonstrate that a competition that is targeted to reverse innovation
does have the potential to mobilize and stimulate leaders to identify reverse innovations that have the potential for
system level impact. The competition also provided important insights into the capacity of Canadian students,
health care providers, entrepreneurs, and innovators to propose and implement reverse innovation in the context
of the Canadian health system.
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Background
Canada’s innovation track record
Every developed country in the world is challenged by
the increasing demands for health services and the rising
costs of health care that are closely associated with rapid
advances in technology and aging populations. Canada is
no exception; it is facing similar challenges, yet has made
less progress in meeting these demands when compared
to other developed countries. Within the context of the
Canadian economy, health care spending totals $207 bil-
lion, representing 11.6% of the national gross domestic
product [1]. As demand continues to outpace the cap-
acity to deliver health services, approaches that embrace
new technologies and leverage innovative processes will
become pivotal to the sustainability of health systems
both within Canada and globally. In Canada, a slow up-
take and adoption of innovative technologies, processes,
and procedures is leading to growing cost pressures on
Canada’s publicly funded health systems which continue
to be challenged to deliver high quality care and value to
Canadians [2].
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Canada leads the world in its population percentage
with completed tertiary education (51%), inclusive of
both undergraduate and graduate degrees [3]. Canada is
also among the top four countries in the world to pro-
duce new knowledge (i.e. publications, patents, technolo-
gies) [4]. Yet, despite a social framework that supports
and encourages Canadians to pursue advanced education
and new knowledge, Canada receives failing grades when
it comes to their ability to adopt innovation. According
to McKinsey & Company, Canada placed 13th out of 17,
earning a “D” grade, among developed nations in this
economic and future prosperity indicator [2,5]. The eco-
nomic and future prosperity indicator ranking indicates
that as a proportion of its overall economic activity and
in comparison to other OECD countries, Canada does
not rely on innovation as much as some of its peer com-
parators [2]. Frequently Canada is viewed a country of
pilot projects that are not scaled or adopted across health
systems to achieve financially sustainable programs with
learnings and/or outcomes that are translated and shared
across provincial or national jurisdictions [6].
Opportunity for reverse innovation
Health systems require constant innovation to control
ballooning costs, to create new knowledge as well as de-
velop more effective and efficient mechanisms of achiev-
ing value for Canadians. To accelerate the adoption and
scalability of successful innovation and thereby support
Canadian health systems to overcome the limitations of
pilot programs, reverse innovation can offer Canada op-
portunities to learn from innovations that are occurring
in developing and/or emerging markets and consider
how these innovations may be translated into the con-
text of the Canadian health system. These reverse inno-
vations are an important opportunity for learning and
building capacity for leading change that has the poten-
tial to optimize resource use while also finding innova-
tive approaches to deliver health services in a cost
effective, sustainable manner. The purpose of this pro-
ject was to examine the potential for reverse innovation
to offer Canadian health systems a new approach to
supporting and strengthening innovation adoption by
learning from global health systems. This manuscript
documents the use of a competition approach to encour-
age Canadians to look beyond national boarders, to de-
veloping and emerging markets, for innovations that can
address current Canadian health system challenges. In
an effort to better understand how the concept of re-
verse innovation could be mobilized amongst Canadians,
the Ivey International Centre for Health Innovation issued
an open call to invite proposals for reverse innovations
that could address Canada’s health system challenges. One
of the key objectives of this initiative was to strengthen
leadership capacity among future leaders to identify and
lead potential reverse innovation projects that address
health system challenges in Canada. A growing base of re-
search indicates that a large proportion of cost and value-
based innovations are coming from emerging markets –
an opportunity for learning which is not evident in the
work of Canadian innovators or health systems [7].
As health systems, in particular those of developed na-
tions, quickly consume the current financial resources to
maintain delivery of high quality care, the concept of
“doing more with less” or “innovation by necessity” plays
a prominent role in the future of these health systems.
Canada’s limited success in health system innovation is
believed to be related to several barriers, including:
1. Lack of Competition: In many countries with
privatized service delivery, private sector companies
are forced to innovate into the mainstream market,
or they will face erosion of existing market position
in the world. This incentive for individual companies
to innovate is not seen to the same extent in publicly
funded systems like in Canada, where there is a lack
of competition [8].
2. Collaboration Challenges: In developed nations
with complex and long standing bureaucratic legacy
systems, collaboration is often difficult due to the
complexity and number of stakeholders in each
health system. In developing countries, the drive for
competition coupled with fewer (or less complex)
bureaucratic systems, the potential for collaboration
is may be more easily overcome.
3. Change-Resistant Culture: Canada is not known
as a culture that embraces change and where
entrepreneurship thrives. Innovators are often met by
a change-resistant culture from the necessary stake-
holders [9].
4. Need for Change: While Canada maintains an
international reputation for delivering high quality
health services with positive patient outcomes, it
presents an increasing financial burden on Canadian
tax payers. Important lessons can be learned from
emerging markets with less developed health systems
that achieve positive patient outcomes with fewer
resources. The idea of “doing more with less” is a
lesson that presents tremendous opportunity to
increase the financial sustainability of the Canadian
health system.
Reverse innovation, the two part process whereby
innovations are designed and created for emerging
markets, and then brought to developed nations, has
the potential to positively affect financially burdened,
developed health systems through quality innovations
at decreased costs [7]. Although Canada could benefit
substantially from reverse innovation, we have not
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been successful at implementing these innovations
into the mainstream market. Canada needs to build
capacity for learning from developing countries, translat-
ing innovations that are occurring into the Canadian con-
text to achieve value for Canadians and sustainability for
health systems. For example, GE Healthcare Worldwide
has created a portable, durable, rechargeable and low-cost
electrocardiogram (ECG) (i.e. MAC i) that was designed
to service rural and low-income areas of India [10,11].
Other examples of reverse innovations that have had ap-
plication to healthcare include crowdsourcing programs
that were developed to map disaster impact and response
to earthquakes as well as service delivery models that have
addressed geographic barriers that restrict access to
conventional medical infrastructure in rural Haiti [10].
Reverse innovations, like those created by GE Healthcare
and those programs and models developed in Haiti, have
the potential to positively affect developed health sys-
tems through quality innovations that achieve value at
decreased costs.
Currently the concept of reverse innovation is emer-
ging as a potential solution for over burdened, financially
constrained health systems [10]. However, the capacity
for Canadians to identify and adopt reverse innovations
into the Canadian context has not been explored to date.
As such there is a need to mobilize Canadian capacity to
identify reverse innovations that have the potential to
positively impact health systems. The Reverse Innovation
Challenge, a cross-sector competition which invites par-
ticipants to identify and test reverse innovations across
the globe to address Canadian health system challenges.
Project goal:
The goal of our project was to examine if a reverse
innovation competition can mobilize capacity among future
leaders to identify potential reverse innovation projects that
address health system challenges in Canada.
For the purposes of this project, mobilizing capacity for
reverse innovation was viewed with the intent of facilitat-
ing an environment, for future and current health system
leaders, to engage in meaningful, constructive dialogue
surrounding the potential for reverse innovation within
the Canadian health system. The competition not only
created an opportunity for health system leaders to engage
the concept of reverse innovation, but also the greater
population at large was engaged through different media
and news outlets successfully generating awareness of the
concept of reverse innovation in Canada.
Approach to the project
Why a competition?
Due to the emerging evidence of the value of reverse
innovation in global communities, the concept was
examined in the Canadian context through an open
competition. Taking an exploratory approach to the con-
struct of the competition would enable any interested
parties to participate and also enable an assessment of
how reverse innovation is perceived. The challenge was
designed to create an environment that encouraged
Canadians to look beyond national borders, identify po-
tential reverse innovation opportunities in emerging and
developing markets, and consider how those innovations
may address challenges within the Canadian health
system.
The format of the competition was based on an envir-
onmental scan of successful competitions, including
discussions with organizations with experience hosting
similar competitions such as: Ashoka Change Makers,
Health Council of Canada and Grand Challenges
Canada, including the provision of a monetary prize to
advance the winning idea from concept to testing in
the Canadian health care context. The competition was
financially supported by a number of partners includ-
ing: Medtronic Canada, GE Healthcare, Telus Health,
Sandra Rotman Centre, Roche Canada and the Institute
for Health System Transformation and Sustainability.
Representatives from each of these organizations formed
an advisory group which informed the planning, structure,
format and process throughout the duration of the
competition.
Further, the concept of the competition was shared
and tested with various experts, beyond the advisory
group and who are considered experts within the fields
of innovation and global health, for feedback and input.
External experts from multiple perspectives were en-
gaged in guiding the process, including: academics,
researchers, clinicians, granting organizations, health
system leaders and industry leaders. All of the stake-
holder comments were taken into consideration and
the concept was refined accordingly. Based on the
feedback and recommendations, the evaluation criteria
was revised to ensure it addressed feasibility, scalabil-
ity and weighted more heavily projects with partner-
ships in emerging markets. The evaluation criterion is
discussed in more detail below.
Building momentum through communication and
awareness
The competition invited the public to identify innova-
tions from emerging markets that could be applicable
in the Canadian context to tackle some of our greatest
health care challenges. While the competition was
open to the general public, the communication strat-
egy focused largely on students, international innova-
tors and entrepreneurs, health system leaders, and
care providers. The communications plan, detailed
below, identified strategies and tactics targeted towards
each of these groups.
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Over the course of the four months, the Centre com-
municated information about the competition via: a ded-
icated website page promoting the challenge; targeted
email outreach to various distribution lists including re-
search institutions and universities across Canada; social
media updates via Facebook and Twitter (#richallenge),
including two online chats. Sponsors of the competition
also promoted the Challenge through their communica-
tions channels; academic and professional speaking en-
gagements where information about the Challenge was
provided; and through the Canadian College of Health
Leaders network, MEDEC and Rx&D communications
vehicles. In addition, the competition launch was sup-
ported by two media outlets: Makeshift Magazine and
Rogers Healthcare Innovation and Research Magazine.
Both media outlets actively promoted the competition
through their print and online channels.
Evaluation criteria and committee
The approach to adjudicating proposals was based on
the two-step process that focused on two central criteria:
(1) feasibility of the proposed emerging market design
and (2) translation of how the identified reverse
innovation is proposed to be adopted into a devel-
oped health system [7]. The evaluation criteria were
designed to ensure that both of these elements were
appropriately addressed and captured in the review
process. One of our key assumptions was that it was
highly possible that there would be no submissions
where the reverse innovation identified had success-
fully been applied or adopted in the Canadian con-
text. Therefore, the criteria required the proposed
innovation must be one that had been implemented
and had demonstrated evidence of its potential for
adoption and scalability. Seven criteria were designed
to help assess the submissions (See Table 1).
The applicants were required to submit a two-minute
video that would describe the concept succinctly and in
a clear and easily understood language. Finally, each sub-
mission required a Canadian project team leader to in-
crease the likelihood of successful implementation and
adoption in a Canadian health system.
Given the limited body of research describing reverse
innovation in health care, and the novelty of the Reverse
Innovation Challenge, an evaluation committee was
established to evaluate the submission. The committee
members we selected based on their experience and
skills to ensure a broad range of perspectives were repre-
sented. Each evaluator was assigned a primary and sec-
ondary submission to review; assignments were based
on the expertise and experience of the reviewer and the
fit with the application. The evaluation committee then
convened in a daylong session to review the submission
videos, hear feedback from the primary and secondary
reviewers for each application and then discuss each
proposal. The criteria were used to score each submis-
sion. Each application was reviewed by the committee
using the criteria to score each submission. Each
Table 1 Evaluation criteria
Criterion Description Value as a % of
overall score
1. Demonstrated Proof of
Concept
Was there documented evidence that the innovation achieved impact in an emerging market/
developing country context? For the purpose of the evaluation the notion of “documented”
was considered broadly and included grey literature.
10%
2. Potential Value to
Canadian Health Systems
Would the proposed innovation achieve value if applied in Canada and if so, would it deliver
value - better outcomes or reduced cost, or both - if adopted in a health system context?
25%
3. Economic Impact if
Implemented
What would be the economic impact for the Canadian economy if the innovation were to be
implemented? Recognizing that this is potentially difficult to measure, for the purpose of the
competition, this criterion was intended to ensure applicants considered broader technological,
societal, economic and political considerations associated with the innovation.
10%
4. Feasibility Did the applicants identify barriers, risks, challenges and enablers/strengths associated with the
innovation and its adoption in the Canadian context and did they provide and strategies to
either mitigate risks or leverage strengths?
15%
5. Potential for Scalability Is there a clear path identified for scaling up the innovation across health systems, beyond a
pilot project, at a broader system level? If so, what conditions, such as policy, reimbursement,
education, culture, data, technology etc., need to be in place to scale the innovation.
25%
6. Use of Prize Money How was the proposed budget going to be used to advance the proposed reverse innovation?
This criterion was seeking a creative yet realistic use of fund and also served as a mechanism
for accountability and transparency for sponsors of the competition.
5%
7. Innovation Team The degree to which the team assembled represents key stakeholders in health systems
(clinicians, industry leaders, policy makers, Canadians) to drive the adoption of the innovation.
This criterion was aimed to drive partnership, collaboration and sharing of learnings across
jurisdictions. Applicants with partnerships in emerging markets where the concept was
developed and tested were weighted more heavily to stress the importance of and attempt to
facilitate bi-directional learning.
10%
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application was assigned two reviewers, scores and re-
views were discussed, after deliberate discussion and
consideration, the committee reached consensus on
the score for each application. Once the committee
scored all of the proposals, the proposals were ranked
and a short list of the top five proposals was deter-
mined and then further discussed and ranked to iden-
tify the top three proposals and finally the highest
ranked proposal.
Outcomes
The Centre officially launched Colour Outside the Lines:
A Reverse Innovation Challenge in Canadian Health
Systems in January 18, 2013. The competition closed on
May 31st, 2013. The winners of the competition were
announced at the Reverse Innovation in Health Care
Conference in November 2013.
During the four-month submission process, the Centre
received a total of 12 submissions. A list of the projects
can be found below in Table 2. Key highlights from the
submissions included:
 Four of the submissions were focused on mHealth
and leveraged the use of smartphones and mobile
apps, two were devices, and three of them were
related to education and communications focused
on health issues.
 Six of the projects focused on immigrant or
aboriginal populations. One of them focused on
seniors and two on women’s health and wellness.
 The backgrounds of the applicants ranged from
undergraduate students, medical students, clinicians,
academics and entrepreneurs.
The literature describing reverse innovation presents
varied definitions of reverse innovation. The committee
engaged in a robust debate and discussion about the def-
inition of reverse innovation and how the applicants
were applying it to the Canadian health system. The
evaluation committee was comprised of members with a
wide range of expertise and leadership experience; all
evaluation committee members were considered experts
in the field(s) of health systems, innovation and/or
reverse innovation. The expertise of the evaluation
Table 2 Summary of competition submissions
Proposal Type of
innovation
Emerging market where innovation
has been applied
Summary
1) Technology India An effective, non-expert operable, non-invasive cardiovascular screening
tool to be used by general medical practitioners.
2) Process Singapore & Japan Through the means of an app, the patient and their families would be able
to centralize all administrative tasks of a hospital visit based on their services
required and receive responses.
3) Process Thailand, Bangladesh, Pakistan, Ethiopia,
& Tanzania
Use of a community health worker (CHW) model who handle routine tasks
in primary care, where intensive follow-up is needed to ensure patients
follow the best treatments.
4) Education India, China, South Africa Development of a set of cross-cultural educational and communication
tools for menopausal women of differing ethnicities to improve
communications between women and their caregivers.
5) Process Thailand Decreasing isolation to improve mental wellness while promoting healthy
eating habits, and encouraging volunteerism for seniors.
6) Technology Kenya & Bangladesh Biometric authentication of ID and key health information, and access health
records or caregiving requirements via data or even SMS.
7) Technology/
mHealth
Malawi Apply the innovative use of radio and new information and communication
technologies—mobile phones, podcasting and cloud-based interactive
voice response services—for health promotion.
8) Technology N/A The use of red lights at night in hospital rooms to permit the secretion of
melatonin and help keeping a good sleep-wake cycle.
9) Technology India A non-mydriatic eye prescreening tool which can detect glaucoma, diabetic
retinopathy and corneal disease with high sensitivity, and minimal invasiveness.
10) Process India, South Africa & Pakistan A pictogram-based toolkit to improve wayfinding on hospital campuses,
and a simplified discharge summary designed with and for patients to
improve the comprehension of medication and care instructions.
11) mHealth N/A mHealth solution to the underuse of radiotherapy in end-of-life cancer
patients.
12) Technology/
mHealth
Southern and southwestern Asia, Tanzania,
Uganda, and Ghana, Serbia, Peru
The use of mobile technology or m-health to transfer information to new
mothers of late preterm infants, with focus on health promotion to
improve efficiency in care following discharge from hospital.
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committee members varied from: information technol-
ogy (IT), medical devices, finance, international/global
health, rural health, aboriginal health, gender/racial
health and social enterprise. As a result of the wide array
of experiences and interpretations of reverse innovation,
the dialogue amongst the evaluation committee lead to a
constructive debate pertaining to the value proposition
affiliated with reverse innovation. The scoring of the
individual competition submissions was varied and was
reflective of the different value perspectives of the com-
mittee members. Ultimately, differences were resolved
through lengthy discussions and consensus agreement
between committee members.
The top five submissions were short-listed and two
submissions were identified as not meeting the criteria
of reverse innovation. The top 5 submissions were able
to demonstrate strong proof of concept and value by ef-
fectively defining how the innovation would achieve
value for the Canadian health system. To varying de-
grees, the top five submissions also acknowledged and
engaged relevant partnerships for successful implemen-
tation and potential for scalability. The five finalists were
then asked to submit some additional information to
provide further clarity on their proposals to the commit-
tee. The additional information requests included:
 Further development and discussion of key
component of the proposal;
 Further consideration to potential challenges with
adoption in Canada including; stakeholder
engagement and how these challenges might be
mitigated;
 Considerations for how the project might be scaled
beyond a pilot in Canada;
 Updates on any progress or work on the project since
submission.
The five finalists were first informed that they were
short-listed and then were asked for permission to pro-
file their application online to engage comments and
feedback from the public online. Their proposals were
posted on the website and comments were welcomed
from the public for a one month period. The intention
was that evaluation committee would use the public
comments aligned with the additional information to
inform their final decision. However, due to technical
challenges with the website, the comments were not
considered in the evaluation process.
The committee reconvened for a second stage evalu-
ation, to evaluate each short listed application to
consider the strengths of the additional information
provided to the committee. Once again, ranking of the
proposals was reviewed and determined based on con-
sensus of the committee. The committee unanimously
agreed on the winner of the challenge. The committee
further determined that only one submission met the re-
quirements and spirit of the competition (#9); this team
was awarded financial support and mentorship to trial
their reverse innovation in the Canadian health system
context. The decision to award only one prize was made
with careful and deliberate consideration by the evalu-
ation committee, based solely on the follow up informa-
tion provided by each of the top five teams. The winning
team was announced on November 26, 2013.
Discussion
The International Centre for Health Innovation at the
Ivey Business School at Western University is now work-
ing with the winning team on a demonstration project
to support implementation of the winning reverse
innovation and will help assess whether its application is
feasible in the Canadian context. The winning team will
report progress over the course of the next 18 months.
Overall, the competition proved to be a successful
mechanism to mobilize the capacity of future leaders to
identify potential reverse innovation projects that ad-
dress Canadian health system challenges. The competi-
tion facilitated constructive dialogue and debate on the
subject of reverse innovation between health system
stakeholders; inclusive of stakeholders from: health
service delivery (e.g. clinicians, etc.), government (i.e.
provincial & federal), private industry (e.g. IT, medical
devices, etc.) and academia. The challenge also leveraged
social media (e.g. Facebook, Twitter, YouTube etc.),
more tradition forms of media (e.g. magazines and news-
papers), as well as academic conferences and symposia
to engage the global community in an effort to mobilize
the capacity of current and future health system leaders;
an effort that established reach to a minimum of
400,000 individuals. While recognizing that the intention
of the reverse innovation competition was to mobilize
capacity to identify reverse innovation projects, it is
important to acknowledge that, as a result of their
participation in and profile received from the reverse
innovation competition, three reverse innovation pro-
jects received funding to trial their reverse innovations
within the Canadian health system. One project re-
ceived funding directly from the prize allocated to the
competition and two other projects received govern-
ment funding.
Recognizing that this entire project was an innovation
unto itself and a learning experience, there were a num-
ber of challenges with the administration of competition
itself. For example, the website was entirely developed
and maintained by a volunteer student team. Due to
technical challenges, the process for the second stage
evaluation did not use those public comments to inform
their decision as it was intended to.
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Another limitation was the novel nature of the con-
cept (applying reverse innovation in a Canadian con-
text), as there was no existing baseline knowledge or
experience for reverse innovation ideation or evaluation
in Canadian health systems, from which the evaluation
committee could assess the submissions. Therefore, the
definition applied for the purpose of the challenge left
significant room for interpretation. Further, the evalu-
ation rubric, adapted from the Centre’s framework for
innovation, had not been tested in this context.
The experience of creating a reverse innovation chal-
lenge offered a significant learning opportunity for the
Ivey International Centre for Health Innovation. It also
raised the profile of reverse innovation discussion and
profile across the country, and provided important in-
sights into the capacity of Canadian students, healthcare
providers, entrepreneurs, and innovators to propose and
implement reverse innovation in the context of Canadian
health systems.
Conclusion
The Colour Outside the Lines: A Reverse Innovation
Competition successfully stimulated future leaders to
identify and lead projects that were driven by reverse in-
novations from emerging and developing markets. The
winning submission of this competition will use the
prize money to implement their reverse innovation in
the Canadian health system and will report on their pro-
gress over the next 18 months.
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